Edgewise Therapeutics Inc. Common Stock vs UDR Inc. Common Stock — how do they compare? Edgewise Therapeutics Inc. Common Stock trades at $37.04 (market cap $3.94B), while UDR Inc. Common Stock trades at $33.9 (market cap $10.93B). The key difference: UDR Inc. Common Stock is far larger — about 2.8× Edgewise Therapeutics Inc. Common Stock's market cap, and UDR Inc. Common Stock pays a 5.12% dividend while Edgewise Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Edgewise Therapeutics Inc. Common Stock for 0 Days and UDR Inc. Common Stock for 0 Days on average.
| EWTX | UDR | |
|---|---|---|
Market Cap | $3.94B | $10.93B |
Volume | 810,104 | 2,607,837 |
Sector | Health | Real Estate |
52-Week High | $48.35 | $41.24 |
52-Week Low | $14.89 | $33.27 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $3.48B | $16.96B |
Dividend Yield | — | 5.12% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapies based on its research in muscle physiology, with a pipeline focused on cardiovascular and cardiometabolic conditions such as hypertrophic cardiomyopathy and heart failure.
Read more on EWTX →UDR, Inc. is a self-administered real estate investment trust that owns, operates, develops, and redevelops multifamily apartment communities across targeted US markets. The company generates income primarily through leasing apartment homes, with a portfolio concentrated in coastal and Sunbelt metropolitan areas.
Read more on UDR →